>>> WE HAVE SEEN SOME
ENCOURAGING TRENDS OF LATE
COMING THE VIRUS.
COVID CASES AND HOSPITALIZATIONS
HAVE FALLEN IN MOST STATES,
FALLING NATIONALLY IN THE PAST
FEW DAYS.
SO THAT’S GOOD.
WE APPEAR TO BE ON THE OTHER
SIDE OF THAT LATEST THIRD WAVE,
BY FAR THE WORST.
ALSO VACCINE NEWS CONTINUES TO
BE A BRIGHT SPOT.
TODAY’S RUSSIA’S TWO-SHOT
VACCINE IS SHOWN TO BE HIGHLY
EFFECTIVE.
PUBLISHED IN THE MEDICAL
JOURNAL, SO ANOTHER VACCINE ON
THE CASE GLOBALLY AND "THE NEW
YORK TIMES" REPORTS, GET THIS,
OUT OF THE ROUGHLY 75,000 PEOPLE
WHO HAVE RECEIVED 1 OF THE 5
VACCINES IN A RESEARCH TRIAL,
NOT A SINGLE PERSON DIED FROM
COVID AND ONLY A FEW PEOPLE
APPEAR TO HAVE BEEN
HOSPITALIZED.
GOOD NEWS.
BUT I’VE REPORTED ON GOOD NEWS
HERE BEFORE AND FOLLOWED BY BAD
NEWS ALWAYS SO WE ARE NOT IN THE
CLEAR.
JOINING ME NOW IS DR. ANTHONY
FAUCI.
GREAT TO HAVE YOU BACK ON, DR.
FAUCI.
LET’S TALK ABOUT VACCINE
EFFICACY.
WE HAVE TALKED A LOT ABOUT THE
NATIONAL PICTURE HERE BUT
SPUTNIK IS A REMINDER THAT THE
WHOLE WORLD’S FIGHTING THIS.
DOES IT MATTER TO AMERICANS THAT
OTHER PLACES GET VACCINATED AND
GET VACCINATION PROGRAMS UP?
>> ABSOLUTELY.
THAT’S WHY IT’S REALLY VERY GOOD
NEWS ABOUT THE SUCCESS OF THE
RUSSIAN TRIAL WHICH SHOWED MORE
THAN A 90% EFFICACY.
THAT’S WHAT YOU WANT.
YOU WANT TO GET THE VIRUS
SUPPRESSED THROUGHOUT THE WORLD
BECAUSE WHEN YOU’RE DEALING WITH
A PANDEMIC IF THERE’S A GOOD
DEGREE OF INFECTION AND SPREAD
IN ANY PART OF THE WORLD IT’S
ALWAYS A THREAT TO WHERE YOU
ARE.
SO IF YOU REALLY WANT TO CRUSH A
PANDEMIC, IT’S GOT TO BE A
GLOBAL EFFORT.
IT’S ONLY VERY IMPORTANT TO BE
SUCCESSFUL AND AS YOU SHOWED THE
CURVE OF THE INFECTIONS GOING
DOWN HOPEFULLY AS WE GET MORE
AND MORE PEOPLE VACCINATED THE
LEVEL OF INFECTION IN OUR OWN
COUNTRY WILL GET LOWER AND LOWER
UNTIL IT REALLY IS NOT A THREAT.
BUT IF WE DO THAT IN A VACUUM,
WITHOUT THE REST OF THE WORLD
ALSO SUPPRESSING THE VIRUS, IT
WILL BE A CONTINUAL THREAT
HANGING OVER US SO IT’S VERY
IMPORTANT THAT THE REST OF THE
WORLD GET VACCINATED.
THAT’S WHY I WAS VERY PLEASED TO
SEE THE RESULT OF THE RUSSIAN
STUDY.
>> ANOTHER VACCINE THAT IS BEING
USED INTERNATIONALLY BUT NOT IN
THE U.S. AS OF YET IS
ASTRAZENECA VACCINE THAT WAS A
JOINT PROJECT WITH OXFORD.
THERE WAS SOME PROBLEMS WITH THE
TRIAL BUT ULTIMATELY IT DID GET
APPROVAL IN THE UK, BEING AND
MIDSTERED IN THE UK AND I HAVE
SEEN SOME PEOPLE, YOU KNOW,
RESPECTSIBLE FOLKS IN THE FIELD
WONDERING IF THE U.S. IS WAITING
TOO LONG ON ASTRAZENECA, IF WE
SHOULD BE PUSHING TO GET THAT
OUT INTO THE HANDS OF AMERICANS
EVEN THOUGH AS YOU SEE THERE
THREE COUNTRIES DO NOT RECOMMEND
IT FOR SENIORS.
>> WELL, THAT IS RIGHT.
THERE IS A LITTLE BIT OF A
CONTROVERSY ABOUT THAT.
I THINK FOR THE MOST PART THE
NEWS IS REASONABLY GOOD BUT WE
HAVE A TRIAL GOING ON RIGHT NOW
IN OUR OWN COUNTRY THAT WE WOULD
LIKE TO SEE THE DATA OF THAT
PHASE THREE TRIAL WHICH IS
SOLID, WELL ORIGINALIZED TRIAL
TO MAKE THE PROPER DECISION
ABOUT THE SAFETY AND THE
EFFICACY AND WHAT PLACE IT HAS
AMONG OTHER VOOECHBACCINES.
IN ADDITION TO MODERNA AND
PFIZER, WE HAVE THE J&J AND THE
TRIAL SHOWED A GOOD DEGREE OF
EFFICACY PARTICULARLY IN ADVANCE
DISEASE.
WE HAVE ANOTHER VACCINE PLATFORM
WHICH IS A SOLUBLE PROTEIN AND
HOPEFULLY WILL GET SOME GOOD
DATA THERE.
SO THERE ARE A LOT OF VACCINES
IN THE MIX HERE RIGHT NOW AND I
BELIEVE THE PROCESS THAT WE’RE
GOING THROUGH THE PROPER PROCESS
TO GET THE GOOD SCIENTIFIC DATA
TO MAKE GOOD PUBLIC HEALTH
DECISIONS.
>> IT’S POSSIBLE THAT YOU HAVE
LOST AUDIO FROM ME SO I’M JUST
SAYING THAT IN CASE.
LET’S DO THIS.
LET’S TAKE A QUICK BREAK AND BE
BACK WITH DR. FAUCI -- WE HAVE
HIM BACK.
YOU GOT ME THERE?
>> I CAN HEAR NOW, CHRIS.
>> GOOD.
SO WHEN YOU TALK ABOUT THE SORT
OF -- WE HAVE A NUMBER OF
VACCINES, RIGHT?
A NUMBER HAVE THE EMERGENCY USE
AUTHORIZATIONS, OTHERS ARE
COMING UP.
MAYBE WE CAN JUST TALK THROUGH
THIS.
TO GET A PERSON VACCINATED IS A
LIKE A THREE CHERRIES ON THE
SLOT MACHINE.
MAKE THE THING AND BE DELIVERED
TO SOMEONE WITH A SYRINGE AND A
PERSON WITH AN ARM WHO WANTS IT.
RIGHT?
WE HAVE TO SUPPLY THE VACCINE,
DELIVER THE VACCINE, WE NEED
DEMAND FOR THE VACCINE.
WHAT IS THE OBSTACLE NOW TO
AMERICAN SCALE?
WHAT IS THE LIMITING CONDITION
ON HOW MANY PEOPLE WE CAN
VACCINATE RIGHT NOW?
>> YEAH.
WELL, THERE IS A VERY MINOR
COMPONENT OF SOME PARTS OF THE
COUNTRY IN WHICH IT IS
INEFFICIENT GETTING INTO THE
ARMS AND SOME VACCINE ON THE
SHELF BUT OVERWHELMINGLY IF YOU
LOOK AT THE ENTIRE COUNTRY THE
SUPPLY DOES NOT AT THIS POINT
MEET THE DEMAND.
>> RIGHT.
>> SO IF YOU GET ON THE PHONE
WITH MAYORS AND GOVERNORS THE
BIGGEST COMPLAINT IS WE NEED
MORE VACCINE.
GET US MORE VACCINE.
THERE ARE A COUPLE OF LOCATIONS
WHERE THEY’RE INEFFICIENT IN
GETTING IT INTO PEOPLE’S ARMS
BUT I’M ON THE PHONE A LOT.
I GOT OFF THE PHONE LITERALLY A
FEW MINUTES AGO WITH A MAYOR OF
A BIG CITY AND THAT’S WHAT THE
PERSON WAS SAYING.
GET US MORE VACCINE.
WE WILL BE DOING BETTER AS WE
GET INTO FEBRUARY AND MARCH AND
APRIL.
THERE WILL BE AN ESCALATION OF
DOSES THAT ARE AVAILABLE NOT
ONLY FROM THE MODERNA AND FROM
THE PFIZER, BUT ALSO, FROM THE
OTHER COMPANIES, THE ONE I